$ABT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ABBOTT LABORATORIES.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ABBOTT LABORATORIES. Get notifications about new insider transactions in ABBOTT LABORATORIES for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 ... 53 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.21 | 494 | 38,636 | 3,586,333 | 3.6 M to 3.6 M (-0.01 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.79 | 7,233 | 569,888 | 3,586,827 | 3.6 M to 3.6 M (-0.20 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.99 | 300 | 23,697 | 3,594,060 | 3.6 M to 3.6 M (-0.01 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 79.90 | 69 | 5,513 | 3,594,360 | 3.6 M to 3.6 M (0.00 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 79.87 | 500 | 39,935 | 3,594,429 | 3.6 M to 3.6 M (-0.01 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.04 | 7,956 | 620,886 | 3,594,929 | 3.6 M to 3.6 M (-0.22 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.67 | 2,277 | 179,132 | 3,602,885 | 3.6 M to 3.6 M (-0.06 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.73 | 700 | 55,108 | 3,605,162 | 3.6 M to 3.6 M (-0.02 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 79.17 | 3,900 | 308,763 | 3,605,862 | 3.6 M to 3.6 M (-0.11 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.48 | 3,337 | 261,888 | 3,609,762 | 3.6 M to 3.6 M (-0.09 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.78 | 805 | 63,414 | 3,613,099 | 3.6 M to 3.6 M (-0.02 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 79.63 | 1,200 | 95,556 | 3,613,904 | 3.6 M to 3.6 M (-0.03 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 79.42 | 800 | 63,536 | 3,615,104 | 3.6 M to 3.6 M (-0.02 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.41 | 1,465 | 114,871 | 3,615,904 | 3.6 M to 3.6 M (-0.04 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 79.22 | 900 | 71,298 | 3,617,369 | 3.6 M to 3.6 M (-0.02 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.16 | 10,974 | 857,728 | 3,618,269 | 3.6 M to 3.6 M (-0.30 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 79.52 | 212 | 16,858 | 3,629,243 | 3.6 M to 3.6 M (-0.01 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 79.00 | 400 | 31,600 | 3,629,455 | 3.6 M to 3.6 M (-0.01 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 79.74 | 1,400 | 111,636 | 3,629,855 | 3.6 M to 3.6 M (-0.04 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.37 | 450 | 35,267 | 3,631,255 | 3.6 M to 3.6 M (-0.01 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 79.48 | 2,915 | 231,684 | 3,631,705 | 3.6 M to 3.6 M (-0.08 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 79.04 | 2,998 | 236,962 | 3,634,620 | 3.6 M to 3.6 M (-0.08 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.83 | 4,185 | 329,904 | 3,637,618 | 3.6 M to 3.6 M (-0.11 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 79.24 | 200 | 15,848 | 3,641,803 | 3.6 M to 3.6 M (-0.01 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.54 | 1,500 | 117,810 | 3,642,003 | 3.6 M to 3.6 M (-0.04 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.57 | 2,262 | 177,725 | 3,643,503 | 3.6 M to 3.6 M (-0.06 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 79.48 | 123 | 9,775 | 3,645,765 | 3.6 M to 3.6 M (0.00 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.45 | 1,100 | 86,295 | 3,645,888 | 3.6 M to 3.6 M (-0.03 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.75 | 1,691 | 133,166 | 3,646,988 | 3.6 M to 3.6 M (-0.05 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.81 | 2,237 | 176,298 | 3,648,679 | 3.7 M to 3.6 M (-0.06 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.85 | 14,095 | 1,111,391 | 3,650,916 | 3.7 M to 3.7 M (-0.38 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.70 | 2,739 | 215,559 | 3,665,011 | 3.7 M to 3.7 M (-0.07 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.22 | 600 | 46,932 | 3,667,750 | 3.7 M to 3.7 M (-0.02 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.27 | 2,261 | 176,968 | 3,668,350 | 3.7 M to 3.7 M (-0.06 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 79.20 | 200 | 15,840 | 3,670,611 | 3.7 M to 3.7 M (-0.01 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.81 | 1,171 | 92,281 | 3,670,811 | 3.7 M to 3.7 M (-0.03 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.20 | 2,206 | 172,509 | 3,671,982 | 3.7 M to 3.7 M (-0.06 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 79.79 | 800 | 63,832 | 3,674,188 | 3.7 M to 3.7 M (-0.02 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.03 | 3,709 | 289,413 | 3,674,988 | 3.7 M to 3.7 M (-0.10 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.18 | 5,675 | 443,672 | 3,678,697 | 3.7 M to 3.7 M (-0.15 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.10 | 3,754 | 293,187 | 3,684,372 | 3.7 M to 3.7 M (-0.10 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Option Exercise | M | 22.39 | 294,700 | 6,598,893 | 0 | |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Option Exercise | M | 26.19 | 295,000 | 7,725,431 | 0 | |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.19 | 4,700 | 367,493 | 3,688,126 | 3.7 M to 3.7 M (-0.13 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.87 | 100 | 7,887 | 3,692,826 | 3.7 M to 3.7 M (0.00 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 79.72 | 100 | 7,972 | 3,692,926 | 3.7 M to 3.7 M (0.00 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.78 | 100 | 7,878 | 3,693,026 | 3.7 M to 3.7 M (0.00 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 79.20 | 3,008 | 238,234 | 3,693,126 | 3.7 M to 3.7 M (-0.08 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.90 | 7,092 | 559,559 | 3,696,134 | 3.7 M to 3.7 M (-0.19 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.90 | 2,649 | 208,993 | 3,703,226 | 3.7 M to 3.7 M (-0.07 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 79.11 | 812 | 64,237 | 3,705,875 | 3.7 M to 3.7 M (-0.02 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.64 | 1,960 | 154,134 | 3,706,687 | 3.7 M to 3.7 M (-0.05 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.97 | 300 | 23,691 | 3,708,647 | 3.7 M to 3.7 M (-0.01 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.41 | 123 | 9,644 | 3,708,947 | 3.7 M to 3.7 M (0.00 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.60 | 100 | 7,860 | 3,709,070 | 3.7 M to 3.7 M (0.00 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.06 | 10,908 | 851,424 | 3,709,170 | 3.7 M to 3.7 M (-0.29 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.13 | 1,725 | 134,774 | 3,720,078 | 3.7 M to 3.7 M (-0.05 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 79.51 | 3,680 | 292,597 | 3,721,803 | 3.7 M to 3.7 M (-0.10 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.71 | 7,800 | 613,938 | 3,725,483 | 3.7 M to 3.7 M (-0.21 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 79.05 | 4,600 | 363,630 | 3,733,283 | 3.7 M to 3.7 M (-0.12 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 79.01 | 5,442 | 429,972 | 3,737,883 | 3.7 M to 3.7 M (-0.15 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 79.12 | 723 | 57,204 | 3,743,325 | 3.7 M to 3.7 M (-0.02 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.07 | 400 | 31,228 | 3,744,048 | 3.7 M to 3.7 M (-0.01 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 79.93 | 100 | 7,993 | 3,744,448 | 3.7 M to 3.7 M (0.00 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 79.69 | 1,130 | 90,050 | 3,744,548 | 3.7 M to 3.7 M (-0.03 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 79.20 | 300 | 23,759 | 3,745,678 | 3.7 M to 3.7 M (-0.01 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 79.53 | 250 | 19,883 | 3,745,978 | 3.7 M to 3.7 M (-0.01 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.96 | 1,683 | 132,890 | 3,746,228 | 3.7 M to 3.7 M (-0.04 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 79.21 | 100 | 7,921 | 3,747,911 | 3.7 M to 3.7 M (0.00 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.15 | 12,383 | 967,731 | 3,748,011 | 3.8 M to 3.7 M (-0.33 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 78.19 | 3,471 | 271,380 | 3,760,394 | 3.8 M to 3.8 M (-0.09 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Buy | M | 22.39 | 294,700 | 6,598,893 | 3,763,865 | 3.5 M to 3.8 M (+8.49 %) |
Mar 20 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Buy | M | 26.19 | 295,000 | 7,725,431 | 3,469,165 | 3.2 M to 3.5 M (+9.29 %) |
Mar 14 2019 | ABT | ABBOTT LABORATORIE ... | BIRD ROGER | Senior Vice Preside ... | Sell | S | 79.07 | 288 | 22,772 | 59,807 | 60.1 K to 59.8 K (-0.48 %) |
Mar 14 2019 | ABT | ABBOTT LABORATORIE ... | BIRD ROGER | Senior Vice Preside ... | Sell | S | 79.07 | 100 | 7,907 | 60,095 | 60.2 K to 60.1 K (-0.17 %) |
Mar 14 2019 | ABT | ABBOTT LABORATORIE ... | BIRD ROGER | Senior Vice Preside ... | Sell | S | 79.06 | 8,800 | 695,737 | 60,195 | 69 K to 60.2 K (-12.75 %) |
Mar 08 2019 | ABT | ABBOTT LABORATORIE ... | Bracken Sharon J | Senior Vice Preside ... | Sell | S | 77.84 | 600 | 46,702 | 44,919 | 45.5 K to 44.9 K (-1.32 %) |
Mar 08 2019 | ABT | ABBOTT LABORATORIE ... | Bracken Sharon J | Senior Vice Preside ... | Sell | S | 77.83 | 100 | 7,783 | 45,519 | 45.6 K to 45.5 K (-0.22 %) |
Mar 08 2019 | ABT | ABBOTT LABORATORIE ... | Bracken Sharon J | Senior Vice Preside ... | Sell | S | 77.83 | 100 | 7,783 | 45,619 | 45.7 K to 45.6 K (-0.22 %) |
Mar 08 2019 | ABT | ABBOTT LABORATORIE ... | Bracken Sharon J | Senior Vice Preside ... | Sell | S | 77.83 | 4,300 | 334,673 | 45,719 | 50 K to 45.7 K (-8.60 %) |
Mar 08 2019 | ABT | ABBOTT LABORATORIE ... | Bracken Sharon J | Senior Vice Preside ... | Sell | S | 77.83 | 400 | 31,132 | 50,019 | 50.4 K to 50 K (-0.79 %) |
Mar 04 2019 | ABT | ABBOTT LABORATORIE ... | YOOR BRIAN B | Executive Vice Pres ... | Sell | S | 78.00 | 2,246 | 175,188 | 114,381 | 116.6 K to 114.4 K (-1.93 %) |
Mar 04 2019 | ABT | ABBOTT LABORATORIE ... | YOOR BRIAN B | Executive Vice Pres ... | Payment of Exercise | F | 77.23 | 13,127 | 1,013,798 | 116,627 | 129.8 K to 116.6 K (-10.12 %) |
Mar 04 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Payment of Exercise | F | 77.23 | 52,302 | 4,039,283 | 3,174,165 | 3.2 M to 3.2 M (-1.62 %) |
Mar 04 2019 | ABT | ABBOTT LABORATORIE ... | Wellisch Alejandro D | Senior Vice Preside ... | Payment of Exercise | F | 77.23 | 2,337 | 180,487 | 12,695 | 15 K to 12.7 K (-15.55 %) |
Mar 04 2019 | ABT | ABBOTT LABORATORIE ... | Wellisch Alejandro D | Senior Vice Preside ... | Grant | A | 0.00 | 6,676 | 0 | 15,032 | 8.4 K to 15 K (+79.89 %) |
Mar 04 2019 | ABT | ABBOTT LABORATORIE ... | Watkin Jared | Senior Vice Preside ... | Sell | S | 78.00 | 1,391 | 108,498 | 74,535 | 75.9 K to 74.5 K (-1.83 %) |
Mar 04 2019 | ABT | ABBOTT LABORATORIE ... | Watkin Jared | Senior Vice Preside ... | Payment of Exercise | F | 77.23 | 8,464 | 653,675 | 75,926 | 84.4 K to 75.9 K (-10.03 %) |
Mar 04 2019 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Sell | S | 78.00 | 1,664 | 129,792 | 106,748 | 108.4 K to 106.7 K (-1.53 %) |
Mar 04 2019 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Payment of Exercise | F | 77.23 | 11,097 | 857,021 | 108,412 | 119.5 K to 108.4 K (-9.29 %) |
Mar 04 2019 | ABT | ABBOTT LABORATORIE ... | PEDERSON MICHAEL J | Senior Vice Preside ... | Payment of Exercise | F | 77.23 | 2,094 | 161,720 | 83,657 | 85.8 K to 83.7 K (-2.44 %) |
Mar 04 2019 | ABT | ABBOTT LABORATORIE ... | MANNING JOSEPH J | Senior Vice Preside ... | Sell | S | 78.00 | 1,223 | 95,394 | 56,142 | 57.4 K to 56.1 K (-2.13 %) |
Mar 04 2019 | ABT | ABBOTT LABORATORIE ... | MANNING JOSEPH J | Senior Vice Preside ... | Payment of Exercise | F | 77.23 | 3,959 | 305,754 | 57,365 | 61.3 K to 57.4 K (-6.46 %) |
Mar 04 2019 | ABT | ABBOTT LABORATORIE ... | MANNING JOSEPH J | Senior Vice Preside ... | Grant | A | 0.00 | 7,288 | 0 | 61,324 | 54 K to 61.3 K (+13.49 %) |
Mar 04 2019 | ABT | ABBOTT LABORATORIE ... | LANE ANDREW H | Executive Vice Pres ... | Payment of Exercise | F | 77.23 | 5,095 | 393,487 | 44,638 | 49.7 K to 44.6 K (-10.24 %) |
Mar 04 2019 | ABT | ABBOTT LABORATORIE ... | LANE ANDREW H | Executive Vice Pres ... | Grant | A | 0.00 | 23,150 | 0 | 49,733 | 26.6 K to 49.7 K (+87.09 %) |
Mar 04 2019 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 78.00 | 2,246 | 175,188 | 169,935 | 172.2 K to 169.9 K (-1.30 %) |
Mar 04 2019 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Payment of Exercise | F | 77.23 | 15,221 | 1,175,518 | 172,181 | 187.4 K to 172.2 K (-8.12 %) |
Mar 04 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Sell | S | 78.28 | 8,726 | 683,045 | 103,446 | 112.2 K to 103.4 K (-7.78 %) |
Mar 04 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Sell | S | 78.28 | 402 | 31,469 | 112,172 | 112.6 K to 112.2 K (-0.36 %) |
Mar 04 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Sell | S | 78.28 | 600 | 46,969 | 112,574 | 113.2 K to 112.6 K (-0.53 %) |
Mar 04 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Sell | S | 78.29 | 1,333 | 104,357 | 113,174 | 114.5 K to 113.2 K (-1.16 %) |
Mar 04 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Sell | S | 78.29 | 300 | 23,487 | 114,507 | 114.8 K to 114.5 K (-0.26 %) |
Mar 04 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Sell | S | 78.30 | 600 | 46,978 | 114,807 | 115.4 K to 114.8 K (-0.52 %) |
Mar 04 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Sell | S | 78.30 | 100 | 7,830 | 115,407 | 115.5 K to 115.4 K (-0.09 %) |
Mar 04 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Sell | S | 78.30 | 300 | 23,490 | 115,507 | 115.8 K to 115.5 K (-0.26 %) |
Mar 04 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Sell | S | 78.31 | 200 | 15,661 | 115,807 | 116 K to 115.8 K (-0.17 %) |
Mar 04 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Payment of Exercise | F | 77.23 | 9,992 | 771,682 | 116,007 | 126 K to 116 K (-7.93 %) |
Mar 04 2019 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Payment of Exercise | F | 77.23 | 9,132 | 705,264 | 308,535 | 317.7 K to 308.5 K (-2.87 %) |
Mar 04 2019 | ABT | ABBOTT LABORATORIE ... | BRYNELSEN CHARLES | Senior Vice Preside ... | Sell | S | 78.00 | 1,002 | 78,156 | 41,111 | 42.1 K to 41.1 K (-2.38 %) |
Mar 04 2019 | ABT | ABBOTT LABORATORIE ... | BRYNELSEN CHARLES | Senior Vice Preside ... | Payment of Exercise | F | 77.23 | 2,309 | 178,324 | 42,113 | 44.4 K to 42.1 K (-5.20 %) |
Mar 04 2019 | ABT | ABBOTT LABORATORIE ... | Bracken Sharon J | Senior Vice Preside ... | Sell | S | 78.00 | 1,224 | 95,472 | 50,419 | 51.6 K to 50.4 K (-2.37 %) |
Mar 04 2019 | ABT | ABBOTT LABORATORIE ... | Bracken Sharon J | Senior Vice Preside ... | Payment of Exercise | F | 77.23 | 4,678 | 361,282 | 51,643 | 56.3 K to 51.6 K (-8.31 %) |
Mar 04 2019 | ABT | ABBOTT LABORATORIE ... | BIRD ROGER | Senior Vice Preside ... | Sell | S | 78.00 | 1,113 | 86,814 | 68,995 | 70.1 K to 69 K (-1.59 %) |
Mar 04 2019 | ABT | ABBOTT LABORATORIE ... | BIRD ROGER | Senior Vice Preside ... | Payment of Exercise | F | 77.23 | 7,087 | 547,329 | 70,108 | 77.2 K to 70.1 K (-9.18 %) |
Mar 04 2019 | ABT | ABBOTT LABORATORIE ... | ALLEN HUBERT L | Executive Vice Pres ... | Sell | S | 78.00 | 2,246 | 175,188 | 146,010 | 148.3 K to 146 K (-1.51 %) |
Mar 04 2019 | ABT | ABBOTT LABORATORIE ... | ALLEN HUBERT L | Executive Vice Pres ... | Payment of Exercise | F | 77.23 | 14,843 | 1,146,325 | 148,256 | 163.1 K to 148.3 K (-9.10 %) |
Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | YOOR BRIAN B | Executive Vice Pres ... | Option Exercise | A | 75.90 | 169,198 | 12,842,128 | 169,198 | |
Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | YOOR BRIAN B | Executive Vice Pres ... | Grant | A | 0.00 | 32,279 | 0 | 129,754 | 97.5 K to 129.8 K (+33.12 %) |
Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Option Exercise | A | 75.90 | 522,272 | 39,640,445 | 522,272 | |
Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Grant | A | 0.00 | 99,637 | 0 | 3,226,467 | 3.1 M to 3.2 M (+3.19 %) |
Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | Wellisch Alejandro D | Senior Vice Preside ... | Option Exercise | A | 75.90 | 81,578 | 6,191,770 | 81,578 | |
Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | Watkin Jared | Senior Vice Preside ... | Option Exercise | A | 75.90 | 108,770 | 8,255,643 | 108,770 | |
Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | Watkin Jared | Senior Vice Preside ... | Grant | A | 0.00 | 20,750 | 0 | 84,390 | 63.6 K to 84.4 K (+32.61 %) |
Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Option Exercise | A | 75.90 | 162,430 | 12,328,437 | 162,430 | |
Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Grant | A | 0.00 | 30,988 | 0 | 119,509 | 88.5 K to 119.5 K (+35.01 %) |
Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | PEDERSON MICHAEL J | Senior Vice Preside ... | Option Exercise | A | 75.90 | 72,513 | 5,503,737 | 72,513 | |
Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | PEDERSON MICHAEL J | Senior Vice Preside ... | Grant | A | 0.00 | 13,833 | 0 | 85,751 | 71.9 K to 85.8 K (+19.23 %) |
Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | MANNING JOSEPH J | Senior Vice Preside ... | Option Exercise | A | 75.90 | 81,578 | 6,191,770 | 81,578 | |
Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | MANNING JOSEPH J | Senior Vice Preside ... | Grant | A | 0.00 | 15,563 | 0 | 54,036 | 38.5 K to 54 K (+40.45 %) |
Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | LANE ANDREW H | Executive Vice Pres ... | Option Exercise | A | 75.90 | 115,055 | 8,732,675 | 115,055 | |
Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | Karam Sammy | Senior Vice Preside ... | Option Exercise | A | 75.90 | 81,578 | 6,191,770 | 81,578 | |
Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | A | 75.90 | 138,121 | 10,483,384 | 138,121 | |
Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Grant | A | 0.00 | 26,350 | 0 | 187,402 | 161.1 K to 187.4 K (+16.36 %) |
Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Senior Vice Preside ... | Option Exercise | A | 75.90 | 122,367 | 9,287,655 | 122,367 | |
Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Senior Vice Preside ... | Grant | A | 0.00 | 23,344 | 0 | 144,673 | 121.3 K to 144.7 K (+19.24 %) |
Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | President and COO | Option Exercise | A | 75.90 | 240,059 | 18,220,478 | 240,059 | |
Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | President and COO | Grant | A | 0.00 | 45,797 | 0 | 116,572 | 70.8 K to 116.6 K (+64.71 %) |
Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Option Exercise | A | 75.90 | 77,045 | 5,847,716 | 77,045 | |
Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Grant | A | 0.00 | 14,698 | 0 | 125,999 | 111.3 K to 126 K (+13.21 %) |
Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Option Exercise | A | 75.90 | 101,519 | 7,705,292 | 101,519 | |
Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Grant | A | 0.00 | 19,367 | 0 | 317,667 | 298.3 K to 317.7 K (+6.49 %) |
Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | BRYNELSEN CHARLES | Senior Vice Preside ... | Option Exercise | A | 75.90 | 81,578 | 6,191,770 | 81,578 | |
Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | BRYNELSEN CHARLES | Senior Vice Preside ... | Grant | A | 0.00 | 15,563 | 0 | 44,422 | 28.9 K to 44.4 K (+53.93 %) |
Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | Bracken Sharon J | Senior Vice Preside ... | Option Exercise | A | 75.90 | 90,642 | 6,879,728 | 90,642 | |
Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | Bracken Sharon J | Senior Vice Preside ... | Grant | A | 0.00 | 17,292 | 0 | 56,321 | 39 K to 56.3 K (+44.31 %) |
Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Option Exercise | A | 75.90 | 148,895 | 11,301,131 | 148,895 | |
Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Grant | A | 0.00 | 28,405 | 0 | 161,563 | 133.2 K to 161.6 K (+21.33 %) |
Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | BIRD ROGER | Senior Vice Preside ... | Option Exercise | A | 75.90 | 99,706 | 7,567,685 | 99,706 | |
Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | BIRD ROGER | Senior Vice Preside ... | Grant | A | 0.00 | 19,021 | 0 | 77,195 | 58.2 K to 77.2 K (+32.70 %) |